Site Search

... is poised to pass a funding bill this week that includes a $2.6 billion increase for medical research at the National Institutes of Health (NIH). The measure, agreed upon by both House and Senate conference committee members, also provides $296 million increase for the National ... and Prevention (CDC), including for skin, prostate and ovarian cancer programs. There is an additional $20 million for the Office on Smoking and Health (OSH).    The bill also includes a measure to raise the federal age of sale for tobacco to 21, extends Medicaid funding for Puerto Rico ... the U.S. territories for two years is critical to helping cancer patients and survivors maintain access to life-saving treatments and follow-up care.    “Similarly, extending funding for federal qualified health centers ensures uninsured and underinsured Americans across the country can ...

Vote YES on SQ 802 Bring Federal Tax Dollars Back to Oklahoma and Expand Health Care for over 200,000 Oklahomans   This June 30, 2020 Oklahoma voters will have an opportunity vote on State Question 802 . SQ 802 will provide an opportunity for  low-income adults and families access to affordable and comprehensive health care coverage through Medicaid expansion.  SQ802 is critical in the fight against cancer . For the 20,530 Oklahomans who will be diagnosed ...

Much of the current health care reform debate is a rehash of issues that have been argued for many years -- government vs. private insurance, insurance market rules, mandated ... a policy perspective. Karen Pollitz, a professor at Georgetown University, released an innovative study that looks at the benefits in actual health plans sold in Massachusetts and how they would affect people who have breast cancer, stroke, or serious diabetes. Pollitz developed a model ...

... and partners are working together to make sure more Kentuckians can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers, are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...